Pediatric gastrointestinal stromal tumor.

Pediatric gastrointestinal stromal tumor (GIST) is a rare entity that can be quite different from its adult counterpart. This report provides a comprehensive review on the diagnosis and management of this tumor in children and adolescents, including its oncogenesis and associated syndromes. Surgery remains a mainstay of treatment, but there are no standard guidelines available at this time regarding the best practice for multimodality therapy as our understanding of the biology of GIST is still in evolution. Therefore, pediatric patients with GIST should be ideally treated in the context of clinical trials at specialized, multidisciplinary centers throughout the course of their disease, especially because these patients may live for years after diagnosis.

[1]  I. Tomlinson,et al.  SDH mutations in cancer. , 2011, Biochimica et biophysica acta.

[2]  E. Wardelmann,et al.  Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS). , 2011, European journal of cancer.

[3]  R. Casadio,et al.  SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. , 2011, Journal of the National Cancer Institute.

[4]  S. Baruchel,et al.  Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study , 2011, Clinical Cancer Research.

[5]  E. Wardelmann,et al.  Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO). , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Werner,et al.  Multifocal gastric gastrointestinal stromal tumors (GISTs) with lymph node metastases in children and young adults: A comparative clinical and histomorphological study of three cases including a new case of Carney triad , 2011, Diagnostic pathology.

[7]  M. Raval,et al.  Adhesive small bowel obstruction in children and adolescents: operative utilization and factors associated with bowel loss. , 2011, Journal of the American College of Surgeons.

[8]  G. Demetri.  Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors. , 2011, Seminars in oncology.

[9]  M. Heinrich,et al.  “Pediatric-type” Gastrointestinal Stromal Tumors in Adults: Distinctive Histology Predicts Genotype and Clinical Behavior , 2011, The American journal of surgical pathology.

[10]  C. Antonescu,et al.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations , 2010, Proceedings of the National Academy of Sciences.

[11]  E. Wardelmann,et al.  Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour , 2010, The British journal of surgery.

[12]  J. Blay,et al.  Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors , 2010, Cancer.

[13]  P. Pisters,et al.  Gastrointestinal stromal tumors: Current management , 2010, Journal of surgical oncology.

[14]  P. Bénit,et al.  SDHA is a tumor suppressor gene causing paraganglioma. , 2010, Human molecular genetics.

[15]  R. Barr.  Imatinib mesylate in children and adolescents with cancer , 2010, Pediatric blood & cancer.

[16]  C. Antonescu,et al.  Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001. , 2010 .

[17]  J. Blay,et al.  Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST). , 2010, European journal of cancer.

[18]  C. Antonescu,et al.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[19]  J. Fletcher,et al.  Gastrointestinal stromal tumors , 2010, Virchows Archiv.

[20]  E. Wardelmann,et al.  Gastrointestinal stromal tumors (GIST) in children and adolescents: A comprehensive review of the current literature , 2009, Pediatric blood & cancer.

[21]  H. Joensuu,et al.  Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. , 2009, European journal of cancer.

[22]  E. van Marck,et al.  An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. , 2009, The Lancet. Oncology.

[23]  A. D. Van den Abbeele,et al.  Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib , 2009, Pediatric blood & cancer.

[24]  W. Brugge,et al.  A guide for the diagnosis and management of gastrointestinal stromal cell tumors , 2009, Nature Reviews Gastroenterology &Hepatology.

[25]  K. Lok,et al.  Endosonographic surveillance of small gastrointestinal tumors originating from muscularis propria. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[26]  M. Schlemmer,et al.  Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  C. Antonescu,et al.  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[28]  R. DeMatteo,et al.  Management of resectable gastrointestinal stromal tumor. , 2009, Hematology/oncology clinics of North America.

[29]  A. Pappo,et al.  Pediatric gastrointestinal stromal tumors. , 2009, Hematology/oncology clinics of North America.

[30]  U. Klinge,et al.  The Gist of Literature on Pediatric GIST: Review of Clinical Presentation , 2009, Journal of pediatric hematology/oncology.

[31]  C. Antonescu,et al.  Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  K. Owzar,et al.  Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Scarpa,et al.  A systematic review on the clinical diagnosis of gastrointestinal stromal tumors , 2008, Journal of surgical oncology.

[34]  Narasimhan P. Agaram,et al.  Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors , 2008, Genes, chromosomes & cancer.

[35]  Narasimhan P. Agaram,et al.  Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors , 2008, Clinical Cancer Research.

[36]  S. Ashley,et al.  How I Do It: Surgical Management of Gastrointestinal Stromal Tumors , 2008, Journal of Gastrointestinal Surgery.

[37]  J. Crowley,et al.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Fletcher,et al.  Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  P. Adamson,et al.  A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study , 2008, Pediatric blood & cancer.

[40]  M. Choi,et al.  Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[41]  J. Fletcher,et al.  Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. , 2007, Cancer research.

[42]  C. Stratakis,et al.  Familial gastrointestinal stromal tumors and germ-line mutations. , 2007, The New England journal of medicine.

[43]  C. Antonescu,et al.  Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors , 2007, Annals of Surgical Oncology.

[44]  A. D. Van den Abbeele,et al.  NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[45]  T. Nishida,et al.  Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection , 2007, Surgical Endoscopy.

[46]  P. Rutkowski,et al.  Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor , 2007, Annals of Surgical Oncology.

[47]  Haesun Choi,et al.  We should desist using RECIST, at least in GIST. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  Haesun Choi,et al.  Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  K. Akahoshi,et al.  Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. , 2007, World journal of gastroenterology.

[50]  J. Jónasson,et al.  Clinical Study on Gastrointestinal Stromal Tumors (GIST) in Iceland, 1990–2003 , 2007, Digestive Diseases and Sciences.

[51]  C. Antonescu,et al.  Results of Tyrosine Kinase Inhibitor Therapy Followed by Surgical Resection for Metastatic Gastrointestinal Stromal Tumor , 2007, Annals of surgery.

[52]  P. Casali,et al.  Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GIST , 2007, Annals of surgery.

[53]  Xin Huang,et al.  Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial , 2006, The Lancet.

[54]  P. Terrier,et al.  Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era , 2006, Annals of Surgical Oncology.

[55]  D. Faigel,et al.  Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection. , 2006, Gastrointestinal endoscopy.

[56]  M. Kimmey,et al.  American Gastroenterological Association Institute technical review on the management of gastric subepithelial masses. , 2006, Gastroenterology.

[57]  Y. Novitsky,et al.  Long-term Outcomes of Laparoscopic Resection of Gastric Gastrointestinal Stromal Tumors , 2006, Annals of surgery.

[58]  J. Desai,et al.  Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  J. Blay,et al.  KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. , 2006, European journal of cancer.

[60]  F. Ris,et al.  An audit of surgical management of gastrointestinal stromal tumours (GIST). , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[61]  T. Kubota,et al.  Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. , 2006, Surgery.

[62]  J. Blay,et al.  Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[63]  O. GonzaloMéndez,et al.  Tumores estromales del estómago , 2006 .

[64]  Eyal Gottlieb,et al.  Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.

[65]  Y. Kajiyama,et al.  Gastrointestinal stromal tumor in a child and review of the literature , 2005, Pediatric Surgery International.

[66]  L. Sobin,et al.  Gastrointestinal Stromal Tumors of the Stomach in Children and Young Adults: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 44 Cases With Long-Term Follow-Up and Review of the Literature , 2005, The American journal of surgical pathology.

[67]  M. Levy,et al.  EUS-guided Trucut biopsy. , 2005, Gastrointestinal endoscopy.

[68]  M. Kimmey,et al.  A prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial masses. , 2005, Gastrointestinal endoscopy.

[69]  M. Pólkowski.  Endoscopic Ultrasound and Endoscopic Ultrasound-Guided Fine-Needle Biopsy for the Diagnosis of Malignant Submucosal Tumors , 2005, Endoscopy.

[70]  A. Pappo,et al.  Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs) , 2005, Pediatric blood & cancer.

[71]  J. Blay,et al.  Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[72]  B. Nilsson,et al.  Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era , 2005, Cancer.

[73]  J. Fletcher,et al.  Biology of gastrointestinal stromal tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  A. Pappo,et al.  Pediatric gastrointestinal stromal tumors and leiomyosarcoma , 2004, Cancer.

[75]  V. Chen,et al.  Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound‐guided fine‐needle aspiration biopsy , 2004, Cancer.

[76]  D. Faigel,et al.  Yield of tissue sampling for submucosal lesions evaluated by EUS. , 2004, Gastrointestinal endoscopy.

[77]  S. Mocellin,et al.  Gastrointestinal stromal tumors: From a surgical to a molecular approach , 2003, International journal of cancer.

[78]  I. Waxman,et al.  Clinical Impact of On-Site Cytopathology Interpretation on Endoscopic Ultrasound-Guided Fine Needle Aspiration , 2003, American Journal of Gastroenterology.

[79]  D. Faigel,et al.  A comparison of EUS features between CD-117 positive GI stromal tumors and CD-117 negative GI spindle cell tumors. , 2003, Gastrointestinal endoscopy.

[80]  B. Gunawan,et al.  Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours , 2003, The British journal of surgery.

[81]  Samuel Singer,et al.  PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.

[82]  V. Chen,et al.  Endoscopic ultrasound‐guided fine‐needle aspiration biopsy , 2002, Cancer.

[83]  N. Soehendra,et al.  Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[84]  J. W. Griffin,et al.  Gastrointestinal Autonomic Nerve Tumor: Immunohistochemical and Molecular Identity With Gastrointestinal Stromal Tumor , 2001, The American journal of surgical pathology.

[85]  D. Brenner,et al.  Estimated risks of radiation-induced fatal cancer from pediatric CT. , 2001, AJR. American journal of roentgenology.

[86]  L. Sobin,et al.  Immunohistochemical Spectrum of GISTs at Different Sites and Their Differential Diagnosis with a Reference to CD117 (KIT) , 2000, Modern Pathology.

[87]  V. Parithivel,et al.  Gastric Stromal Tumor , 2000, The American surgeon.

[88]  E. Melzer,et al.  The natural course of upper gastrointestinal submucosal tumors: an endoscopic ultrasound survey. , 2000, The Israel Medical Association journal : IMAJ.

[89]  L. Palazzo,et al.  Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours , 2000, Gut.

[90]  J. Carney,et al.  Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. , 1999, Mayo Clinic proceedings.

[91]  A. Sahai,et al.  Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience , 1999, Gut.

[92]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[93]  S. Carpenter,et al.  Endosonographic differentiation of benign and malignant stromal cell tumors. , 1997, Gastrointestinal endoscopy.

[94]  J. Seitz,et al.  Fine-Needle Aspiration Cytology Guided by Endoscopic Ultrasonography: Results in 141 Patients , 1995, Endoscopy.

[95]  M. Wiersema,et al.  Combined endosonography and fine-needle aspiration cytology in the evaluation of gastrointestinal lesions. , 1994, Gastrointestinal endoscopy.

[96]  J. Hedenbro,et al.  Endoscopic diagnosis of submucosal gastric lesions , 1991, Surgical Endoscopy.

[97]  M. Mazur,et al.  Gastric stromal tumors Reappraisal of histogenesis , 1983, The American journal of surgical pathology.

[98]  F. LaRusso.  AMERICAN GASTROENTEROLOGICAL ASSOCIATION (AGA) INSTITUTE , 2011 .

[99]  Jean-Yves Scoazec,et al.  BRAF mutation status in gastrointestinal stromal tumors. , 2010, American journal of clinical pathology.

[100]  Liang-Che Chang,et al.  The role of endoscopic ultrasonography examination for evaluation and surveillance of gastric subepithelial masses. , 2010, Chang Gung medical journal.

[101]  J. Ellison,et al.  Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD , 2008, European Journal of Human Genetics.

[102]  J. Clain,et al.  Preliminary experience with an EUS-guided trucut biopsy needle compared with EUS-guided FNA. , 2003, Gastrointestinal endoscopy.

[103]  Y. Hirooka,et al.  The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. , 2002, Gastrointestinal endoscopy.

[104]  A. Davis,et al.  Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective Database , 2001, Annals of Surgical Oncology.

[105]  M. Catalano,et al.  Interobserver agreement for EUS in the evaluation and diagnosis of submucosal masses. , 2001, Gastrointestinal endoscopy.

[106]  R. DeMatteo,et al.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.

[107]  M. Chintagumpala,et al.  Gastrointestinal autonomic nerve tumors in the pediatric population , 1999 .